tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
ENSC
Ensysce Biosciences
RESEARCH TOOLSreports

Ensysce Biosciences (ENSC) Income Statement

304 Followers

Ensysce Biosciences Income Statement

Last quarter (Q4 2025), Ensysce Biosciences's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Ensysce Biosciences's net income was $-2.77M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 5.21M$ 2.23M$ 2.52M$ 3.53M
Gross Profit
$ 0.00$ -2.01M$ -5.36M$ -17.31M$ 3.53M
Operating Expenses
$ 10.24M$ 4.72M$ 5.36M$ 6.91M$ 23.40M
Depreciation and Amortization
$ 6.53K$ 4.00$ -3.00$ 151.00$ 151.00
EBITDA
$ -10.15M$ -6.73M$ -10.72M$ -24.22M$ -25.93M
Operating Income
$ -10.24T$ -6.73M$ -10.72M$ -24.22M$ -19.87M
Other Income/Expenses
$ 65.25B$ -1.26M$ 91.91K$ 14.41K$ -9.28M
Pretax Income
$ -10.18T$ -7.99M$ -10.63M$ -24.21M$ -29.15M
Net Income
$ -10.18T$ -7.99M$ -10.61M$ -24.17M$ -29.08M
Per Share Metrics
Basic EPS
$ -3.98$ -4.57$ -4.69$ -139.44$ -355.68
Diluted EPS
$ -397.90K$ -4.57$ -4.69$ -139.44$ -355.68
Weighted Average Shares Outstanding
 2.56M 1.75M 2.26M 179.93K 84.02K
Weighted Average Shares Outstanding (Diluted)
 25.57M 1.75M 2.26M 179.93K 84.02K
Currency in USD

Ensysce Biosciences Earnings and Revenue History